Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

International Journal of Cancer

Volumn 70, Issue 6, 1997, Pages 706-718

  Nair, Smita K ^a   Snyder, David ^a   Rouse, Barry T ^b   Gilboa, Eli ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR EXTRACT; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BLADDER CANCER; CANCER; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; FEMALE; LUNG METASTASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0030966684     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970317)70:6<706::AID-IJC13>3.0.CO;2-7     Document Type: Article

References (24)

1. ANICHINI, A., MORTARINI, R., MACCALLI, C., SQUARCINA, P., FLEISCHHAUER, K., MASCHERONI, E. and PARMIANI, G., Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J. Immunol., 156, 208-217 (1996).
2. BANNERJI, R., ARROYO, C.D., CORDON-CARDO, C. and GILBOA, E., The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity. J. Immunol., 152, 2324-2332 (1994).
3. BEVAN, M.J., Antigen presentation to cytotoxic T lymphocytes in vivo. J. exp. Med., 182, 639-641 (1995).
4. BOON, T., CEROTTINI, J. and VAN DEN EYNDE, B., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994).
5. COHEN, P.J., COHEN, P.A., ROSENBERG, S.A., KATZ, S.I. and MULÉ, J.J., Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Europ. J. Immunol., 24, 315-319 (1994).
6. CONNOR, J., BANNERJI, R., SAITO, S., HESTON, W., FAIR, W. and GILBOA, E., Regression of bladder tumors in mice treated with IL-2 gene-modified tumor cells. J. exp. Med., 177, 1127-1133 (1993).
7. FLAMAND, V., SORNASSE, T., THIELEMANS, K., DEMANET, C., BAKKUS, M., BAZIN, H., TIELEMANS, F., LEO, O., URBAIN, J. and MOSER, M., Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Europ. J. Immunol., 24, 605-610 (1994).
8. GILBOA, E. and LYERLY, H.K., Specific active immunotherapy of cancer using genetically modified tumor vaccines. In: Biologic Therapy of Cancer Updates, Vol. 4, pp. 1-16, J.B. Lippincott, Philadelphia (1994).
9. GRABBE, S., BRUVERS, S., GALLO, R.L., KNISELY, T.L., NAZARENO, R. and GRANSTEIN, R.D., Tumor antigen presentation by murine epidermal cells. J. Immunol., 146, 3656-3661 (1991).
10. GREENBERG, P.D., Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol., 49, 281-355 (1991).
11. HUANG, A.Y.C., GOLUMBEK, P., AHMADZADEH, M., JAFFEE, E., PARDOLL, D. and LEVITSKY, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264, 961-965 (1994).
12. LAFFERTY, K.J., PROWSE, S.J., SIMEONOVIC, C.J. and WARREN, H.S., Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Ann. Rev. Immunol., 1, 143-190 (1983).
13. MATZINGER, P. and BEVAN, M., Induction of H-2 restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell. Immunol., 33, 92-100 (1977).
14. MCKINNEY, E.G. and STREILEIN, J.W., On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J. Immunol., 143, 1560-1564 (1989).
15. MOORE, M.W., CARBONE, F.R. and BEVAN, M.J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54, 777-785 (1988).
16. NAIR, S., BABU, J.S., DUNHAM, R.G., KANDA, P., BURKE, R.L. and ROUSE, B.T., Induction of primary, antiviral cytotoxic and proliferative responses with antigens administered via dendritic cells. J. Virol., 67, 4062-4069 (1993).
17. PORGADOR, A., TZEHOVAL, E., VADAI, E., FELDMAN, M. and EISENBACH, L., Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Cancer Res., 55, 4941-4949 (1995).
18. ROCK, K.L., ROTHSTEIN, L., GAMBLE, S. and FLEISCHACKER, C., Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol., 150, 438-446 (1993).
19. ROUSE, R.J.D., NAIR, S.K., LYDY, S.L., BOWEN, J.C. and ROUSE, B.T., Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol., 68, 5685-5689 (1994).
20. SAITO, S., BANNERJI, R., GANSBACHER, B., ROSENTHAL, F.M., ROMANENKO, P., HESTON, W., FAIR, W. and GILBOA, E., Immunotherapy of bladder cancer with cytokine sene-modified tumor vaccines. Cancer Res., 54, 3516-3520 (1994).
21. SHIMIZU, J., SUDA, T., YOSHIOKA, T., KOSUGI, A., FUJIWARA, H. and HAMAOKA, T., Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. J. Immunol., 142, 1053-1059 (1989).
22. STEINMAN, R.M., The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9, 271-296 (1991).
23. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol., 5, 849-857 (1993).
24. ZITVOGEL, L., MAYORDOMO, J.I., TJANDRAWAN, T., DELEO, A.B., CLARKE, M.R., LOTZE, M.T. and STORKUS, W.J., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J exp. Med., 183, 87-97 (1996).